4//SEC Filing
PERELMAN RONALD O 4
Accession 0001140361-20-026446
CIK 0001641489other
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 4:45 PM ET
Size
8.6 KB
Accession
0001140361-20-026446
Insider Transaction Report
Form 4
PERELMAN RONALD O
10% Owner
Transactions
- Purchase
Class A Common Stock
2020-11-24$1.60/sh+625,000$1,000,000→ 35,356,212 total(indirect: See footnote) - Exercise Out-of-Money
Call Option (right to buy)
2020-11-24−1→ 1 total(indirect: See footnote)Exercise: $1.60From: 2019-12-23Exp: 2020-12-23→ Class A common stock (625,000 underlying)
Footnotes (2)
- [F1]The ROP Revocable Trust dated 1/9/2018 (the "ROP Revocable Trust"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of MacAndrews & Forbes Group LLC ("M&F Group"). M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the "Issuer") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC.
- [F2]On December 23, 2019, M&F Group entered into a letter agreement (the "Letter Agreement"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the "Investment Period"), the Issuer's Class A common stock, par value $0.01 per share ("Common Stock"), at a per share price of $1.60. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On November 24, 2020, the Issuer exercised its right to have M&F Group purchase 625,000 shares of Common Stock for a total purchase price of $1,000,000 in cash.
Documents
Issuer
vTv Therapeutics Inc.
CIK 0001641489
Entity typeother
Related Parties
1- filerCIK 0001186472
Filing Metadata
- Form type
- 4
- Filed
- Nov 23, 7:00 PM ET
- Accepted
- Nov 24, 4:45 PM ET
- Size
- 8.6 KB